Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter

More in Hematology-Oncology

1:45 Romidepsin effective for refractory peripheral T-cell lymphoma

Reuters Health • The Doctor's Channel Daily Newscast

Romidepsin effective for refractory peripheral T-cell lymphoma

Jan 30, 2012  | Hematology-Oncology, Oncology, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – About one in four patients with peripheral T-cell lymphoma (PTCL) who do not respond to or relapse after systemic therapy are likely to have an objective response to romidepsin, a potent histone deacetylase inhibitor, according to the results of an open-label, phase II...
More...
1:28 Benefit of rituximab-EPOCH for HIV-related lymphoma confirmed

Reuters Health • The Doctor's Channel Daily Newscast

Benefit of rituximab-EPOCH for HIV-related lymphoma confirmed

Dec 29, 2011  | Hematology-Oncology, HIV/AIDS, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – A pooled analysis of two trials indicates that HIV patients with aggressive B-cell non-Hodgkin lymphoma (NHL) fare better with a regimen of rituximab combined with EPOCH chemotherapy than rituximab plus CHOP chemotherapy.  “Benefits were observed in both high-risk and...
More...
1:42 CNS prophylaxis for diffuse large cell no longer needed

Reuters Health • The Doctor's Channel Daily Newscast

CNS prophylaxis for diffuse large cell no longer needed

Nov 23, 2011  | Hematology-Oncology, Oncology, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – In the rituximab era, it’s not necessary to administer prophylaxis against central nervous system (CNS) disease in patients with diffuse large B-cell lymphoma (DLBCL), according to “real world” data from a large national database. The data confirm a low rate of CNS...
More...
1:28 Extended drainage after pericardiocentesis reduces recurrence of tamponade

Extended drainage after pericardiocentesis reduces recurrence of tamponade

Oct 7, 2011
1:43 ASCO reclassifies anthracycline plus cyclophosphamide as highly emetogenic

ASCO reclassifies anthracycline plus cyclophosphamide as highly emetogenic

Oct 3, 2011
1:16 Early monitoring for anthracycline-related cardiotoxicity has little clinical impact

Early monitoring for anthracycline-related cardiotoxicity has little clinical impact

Sep 26, 2011
1:32 Febrile neutropenia can be safely managed at home

Febrile neutropenia can be safely managed at home

Sep 23, 2011
2:09 Support for partial nephrectomy in clinical T1 renal cell carcinoma

Support for partial nephrectomy in clinical T1 renal cell carcinoma

Sep 22, 2011
1:38 Stereotactic radiosurgery has advantages in treating brain metastases

Stereotactic radiosurgery has advantages in treating brain metastases

Sep 21, 2011
1:20 Endobronchial biopsy samples better with cryoprobe than forceps

Endobronchial biopsy samples better with cryoprobe than forceps

Sep 16, 2011
1:38 Choroidal melanomas near optic nerve treatable with proton irradiation

Choroidal melanomas near optic nerve treatable with proton irradiation

Sep 15, 2011
1:29 Colon cancer staging not changed with increased lymph node evaluation

Colon cancer staging not changed with increased lymph node evaluation

Sep 15, 2011
1:46 Worse outcomes after spinal metastases surgery at academic medical centers in July

Worse outcomes after spinal metastases surgery at academic medical centers in July

Sep 14, 2011
1:32 Barrett’s esophagus ablation can bury metaplastic glands

Barrett’s esophagus ablation can bury metaplastic glands

Sep 14, 2011
1:38 Combined adjuvant therapies improve outcome of high-risk prostate cancer

Combined adjuvant therapies improve outcome of high-risk prostate cancer

Sep 12, 2011
1:50 ASCO tweaks clinical guidance on maintenance therapy in stage IV NSCLC

ASCO tweaks clinical guidance on maintenance therapy in stage IV NSCLC

Sep 9, 2011
1:45 Ovarian ablation not recommended routinely for premenopausal breast cancer

Ovarian ablation not recommended routinely for premenopausal breast cancer

Sep 8, 2011
1:36 Risk of second cancer confirmed after EBRT for testicular seminoma

Risk of second cancer confirmed after EBRT for testicular seminoma

Sep 7, 2011
1:18 Dexamethasone may help injured lungs in monocytic leukemia

Dexamethasone may help injured lungs in monocytic leukemia

Aug 31, 2011
1:57 Surgery should be first treatment for intracranial hemangiopericytoma

Surgery should be first treatment for intracranial hemangiopericytoma

Aug 30, 2011
1:35 Epirubicin-ifosfamide combination effective in small cell lung cancer

Epirubicin-ifosfamide combination effective in small cell lung cancer

Aug 30, 2011
1:36 Cervical preparation before outpatient hysteroscopy does not reduce pain

Cervical preparation before outpatient hysteroscopy does not reduce pain

Aug 25, 2011
1:35 Surgery rates tied to lung cancer outcome in elderly

Surgery rates tied to lung cancer outcome in elderly

Aug 24, 2011
1:36 Early celiac plexus neurolysis has benefits in pancreatic cancer patients

Early celiac plexus neurolysis has benefits in pancreatic cancer patients

Aug 24, 2011
1:30 Ovarian cysts not a cancer risk factor

Ovarian cysts not a cancer risk factor

Aug 23, 2011
1:31 Transthoracic and transhiatal surgery equivalent for esophagogastric cancer

Transthoracic and transhiatal surgery equivalent for esophagogastric cancer

Aug 22, 2011
1:45 Peg-doxorubicin an option in chemo combination for ovarian cancer

Peg-doxorubicin an option in chemo combination for ovarian cancer

Aug 18, 2011
2:00 Lung dysfunction common after childhood irradiation

Lung dysfunction common after childhood irradiation

Aug 16, 2011
1:35 Iodine radioisotope therapy effective for bone metastases from thyroid cancer

Iodine radioisotope therapy effective for bone metastases from thyroid cancer

Aug 15, 2011
1:31 Combining chemo with erlotinib no benefit in advanced lung cancer

Combining chemo with erlotinib no benefit in advanced lung cancer

Aug 12, 2011
12345...Last »